It's crucial for anyone with Parkinson's to consult with their neurologist or physical therapist before starting an exercise program. They can assess the current state, recommend the most suitable ...

A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.

With around one million people living with Parkinson’s disease in the U.S. — and 90,000 getting new diagnoses each year — the race is on for a cure. Researchers at Memorial Sloan Kettering ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday.. The ...

Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors ...

Feb. 6. 2025 – The FDA has approved a new wearable device for adults with advanced Parkinson’s disease. Sold as Onapgo, this device gives a steady dose of apomorphine – a medicine that helps ...

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease. npj Parkinson's Disease , 2025; 11 (1) DOI: 10.1038/s41531-025-00870-y Cite This ...

Treatment for Parkinson's focuses on managing its many symptoms, as there is no cure. But a new stem cell therapy developed at Memorial Sloan Kettering Cancer Center for advanced Parkinson's is ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.